iCLASS Live-Cell Proteomics Access

Summary

Gain scalable, platform-based access to live-cell chemoproteomics data and insights that accelerate target evaluation, reduce discovery risk, and enable collaboration across biotech, pharma, and academic partners. Access provides a practical, platform-driven path to understanding target druggability at scale, with a shared data layer and a flexible access model that eliminates siloed, bespoke pricing.

Primary Outcome

Users gain scalable, platform-backed access to live-cell chemoproteomics data and insights that accelerate early drug discovery and target validation.

Who This Is For

• Director of R&D or Head of Discovery at a biotech startup seeking scalable proteomics data to evaluate targets
• Pharma discovery team lead evaluating target druggability with live-cell insights for candidate prioritization
• Academic drug discovery program director looking for platform-scale data access to accelerate projects

What You'll Learn

• shared data layer
• scalable insights
• flexible access

Metadata

Category

Founders

Creator

Diana Kraskouskaya

Creator Title

Building Value for Discovery Biotech | ​>$1B in Deals | $100M+ Revenue | ​>$40M Raised | CEO & Entrepreneur | Serial Founder

Tags

Startup Ideas, Metrics, Go-To-Market, Scaling

Published

2026-02-20

Last Updated

2026-02-22

Citation

"iCLASS Live-Cell Proteomics Access" by Diana Kraskouskaya, PlaybookHub — https://playbooks.rohansingh.io/playbook/iclass-live-cell-access

Canonical URL